The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -65.81%. However, over the past six months, we’ve seen a stronger performance of -59.90%. The price of NLSP leaped by -31.46% over the last 30 days. And in the last five days, it has fallen by -10.91%.
The stock price for NLS Pharmaceutics Ltd (NLSP) currently stands at $0.44. The stock experienced a substantial increase in the last session, hitting $0.50 after starting at $0.39. The stock’s lowest price was $0.371 before closing at $0.35.
The market performance of NLS Pharmaceutics Ltd’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.88 on 01/13/23, while the lowest value for the same duration was $0.26 on 11/16/23.
52-week price history of NLSP Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. NLS Pharmaceutics Ltd’s current trading price is -76.54% away from its 52-week high, while its distance from the 52-week low is 69.65%. The stock’s price range during this period has varied between$0.26 and $1.88. The NLS Pharmaceutics Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 0.5 million for the day, a figure considerably higher than their average daily volume of 0.14 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
NLS Pharmaceutics Ltd (NLSP) has experienced a quarterly decline of -54.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.30M and boasts a workforce of 2 employees.
NLS Pharmaceutics Ltd: Analysts’ Ratings Unveiled
As of right now, 1 analyst is rating NLS Pharmaceutics Ltd as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8137, with a change in price of -0.4789. Similarly, NLS Pharmaceutics Ltd recorded 175,442 in trading volume during the last 100 days, posting a change of -52.05%.
NLSP’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NLSP stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
NLSP Stock Stochastic Average
As of today, NLS Pharmaceutics Ltd’s raw stochastic average for the last 50 days stands at 23.99%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 37.55%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 22.78% and 18.69%, respectively.